A Study of SHR-1918 In Participants With Hypertriglyceridemia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 367 participants.
Also called NCT07349615
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 367 participants
- Registry
-
NCT07349615
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT07349615. Randomized; quadruple masking; primary purpose treatment. Start 2026-03-31 (actual); primary completion 2027-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of SHR-1918 In Participants With Hypertriglyceridemia
- Condition
- Hypertriglyceridemia
- Intervention (Drug)
- SHR-1918/ SHR-1918 placebo
- Intervention (Drug)
- SHR-1918/ SHR-1918 placebo
- Lead sponsor
- Beijing Suncadia Pharmaceuticals Co., Ltd
Record details
- Record id
cardio:ct-nct07349615- Content hash
09f97d1210401a9ba30871a2316c7e9f2f6f1fa0001598fdcaf22e5d295fb06f